Does add-on therapy with Chinese herb medicine Bo-Er-Ning capsule (BENC) improve the outcomes of gastric cancer patients?

Not Applicable

Completed

• Conditions: Advanced gastric cancer; Cancer; Stomach, unspecified

• Registration Number: ISRCTN17186893
• Lead Sponsor: Zhangqiu People's Hospital of Shandong

Brief Summary

2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/30034946

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2012-06-30
• Study Start: 2018-03-24
• Last Update Posted: 11 February 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

1. Age from 25 to 75 years
2. All patients were pathologically confirmed for stage IV or postoperative recurrence and metastasis GC
3. Karnofsky performance score (KPS) = 80
4. No previous anticancer therapy
5. No dysfunction of heart, liver, lung and kidney

Exclusion Criteria

1. Age<25 and >75 years
2. Patients were not pathologically confirmed for stage IV or postoperative recurrence and metastasis GC
3. Karnofsky performance score (KPS) < 80
4. Possess previous anticancer therapy
5. Possess dysfunction of heart, liver, lung and kidney

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> Measured at week 9 (after 3 cycles of chemotherapy):<br> 1. Appetite, assessed by filling out answer sheets<br> 2. Karnofsky performance score (KPS), assessed by filling out answer sheets<br> 3. Body weight, measured using a weight scale<br>

Secondary Outcome Measures

Name	Time	Method
3-year overall survival: patients followed up by clinic visit, phone, or mail at least once every 6 months starting from day 1 after the treatment